AboGen Overview

  • Founded
  • 2011
Founded
  • Status
  • Out of Business
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Out of Business

AboGen General Information

Description

Developer of a medical device designed to preserve components of saliva for medical tests. The company's medical device uses a saliva collection and preservation technology to preserve all the components in saliva and replace blood tests performed annually, enabling physicians to reduce blood tests and increase diagnosis accuracy.

Contact Information

Website
abogen.com
Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • 477 Congress Street
  • Suite 1010
  • Portland, ME 04101
  • United States
+1 (207) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AboGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 22-Jul-2019 00000 Completed Out of Business
2. Angel (individual) 28-Jul-2017 00000 00000 Completed Generating Revenue
1. Debt - General 16-Dec-2013 $430K $430K Completed Generating Revenue
To view AboGen’s complete valuation and funding history, request access »

AboGen Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

AboGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10576468-B2 Devices, solutions and methods for sample collection Active 20-Jan-2014 000000000 0
JP-6704851-B2 Devices, solutions, and methods for sample collection Active 20-Jan-2014 000000000
US-20200398267-A1 Devices, solutions and methods for sample collection Pending 20-Jan-2014 000000000
US-20170001191-A1 Devices, solutions and methods for sample collection Granted 20-Jan-2014 000000000 0
JP-2017507326-A Devices, solutions, and methods for sample collection Granted 20-Jan-2014 B01L3/502
To view AboGen’s complete patent history, request access »

AboGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial